Deng, M., Zhang, M., Xu-Monette, Z. Y., Pham, L. V., Tzankov, A., Visco, C., . . . Young, K. H. (2020). XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53. BMC.
Citação norma ChicagoDeng, Manman, et al. XPO1 Expression Worsens the Prognosis of Unfavorable DLBCL That Can Be Effectively Targeted By Selinexor in the Absence of Mutant P53. BMC, 2020.
MLA citiranjeDeng, Manman, et al. XPO1 Expression Worsens the Prognosis of Unfavorable DLBCL That Can Be Effectively Targeted By Selinexor in the Absence of Mutant P53. BMC, 2020.
Opozorilo: Ti citati niso vedno 100% točni.